Literature DB >> 7814858

Serum sodium concentration and risk of stroke in middle-aged males.

G Wannamethee1, P H Whincup, A G Shaper, A F Lever.   

Abstract

BACKGROUND AND METHODS: Clinical disturbances of the circulating sodium concentration are both a cause and a consequence of cerebrovascular disease. We examined the relationship between serum sodium level and risk of stroke and major ischaemic heart disease in a prospective study of 7690 middle-aged males drawn from general practices in 24 British towns followed over a 9.5-year period.
RESULTS: The mean serum sodium level was 141.5 mmol/l and 375 males on antihypertensive treatment were excluded from the analyses. A significant inverse trend was seen between serum sodium and risk of stroke up to 144 mmol/l; above this the risk of stroke was increased. Those with levels of 143-144 mmol/l showed over a 70% reduction in risk of stroke compared with those with levels of < or = 140 mmol/l. The inverse relationship between sodium and stroke up to 144 mmol/l was seen in males with and without pre-existing ischaemic heart disease or stroke, in normotensives and untreated hypertensives, and in non-smokers and current smokers. A weak but significant inverse association was seen between serum sodium and diastolic but not systolic blood pressure. The association between serum sodium level and stroke remained significant after adjustment for diastolic blood pressure and other factors associated with stroke: age, smoking, social class, body mass index, physical activity, heavy drinking, presence of diabetes, blood glucose and pre-existing ischaemic heart disease. No association was seen between serum sodium level and risk of ischaemic heart disease after adjustment for other risk factors. All-cause and non-cardiovascular mortality were significantly increased at serum sodium levels of < or = 138 mmol/l, probably due to an association between lung cancer and hyponatraemia.
CONCLUSION: These findings suggest that sodium concentration may be related to risk of stroke even at levels of sodium usually regarded as normal.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814858

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  13 in total

1.  Association between pre hemodialysis serum sodium concentration and blood pressure: results from a retrospective analysis from the international monitoring dialysis outcomes (MONDO) initiative.

Authors:  J G Raimann; B Canaud; M Etter; J P Kooman; N W Levin; D Marcelli; C Marelli; A Power; N Duncan; F M van der Sande; P Carioni; S Thijssen; X Xu; L A Usvyat; Y Wang; P Kotanko
Journal:  J Hum Hypertens       Date:  2015-07-30       Impact factor: 3.012

Review 2.  Sympathetic Nervous System Contributions to Hypertension: Updates and Therapeutic Relevance.

Authors:  Leon J DeLalio; Alan F Sved; Sean D Stocker
Journal:  Can J Cardiol       Date:  2020-03-06       Impact factor: 5.223

Review 3.  Salt and sugar: their effects on blood pressure.

Authors:  Feng J He; Graham A MacGregor
Journal:  Pflugers Arch       Date:  2014-12-30       Impact factor: 3.657

4.  Interindividual variation in serum sodium and longitudinal blood pressure tracking in the Framingham Heart Study.

Authors:  Rodrigo M Lago; Michael J Pencina; Thomas J Wang; Katherine J Lanier; Ralph B D'Agostino; William B Kannel; Ramachandran S Vasan
Journal:  J Hypertens       Date:  2008-11       Impact factor: 4.844

5.  Hyponatremia Predicts New-Onset Cardiovascular Events in Peritoneal Dialysis Patients.

Authors:  Hyung Woo Kim; Geun Woo Ryu; Cheol Ho Park; Ea Wha Kang; Jung Tak Park; Seung Hyeok Han; Tae-Hyun Yoo; Sug Kyun Shin; Shin-Wook Kang; Kyu Hun Choi; Dae Suk Han; Tae Ik Chang
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

6.  Small increases in plasma sodium are associated with higher risk of mortality in a healthy population.

Authors:  Se Won Oh; Seon Ha Baek; Jung Nam An; Ho Suk Goo; Sejoong Kim; Ki Young Na; Dong Wan Chae; Suhnggwon Kim; Ho Jun Chin
Journal:  J Korean Med Sci       Date:  2013-07-03       Impact factor: 2.153

Review 7.  Variation in macro and trace elements in progression of type 2 diabetes.

Authors:  Khalid Siddiqui; Nahla Bawazeer; Salini Scaria Joy
Journal:  ScientificWorldJournal       Date:  2014-08-05

8.  Evaluation of influence of chronic kidney disease and sodium disturbances on clinical course of acute and sub-acute stage first-ever ischemic stroke.

Authors:  Anetta Lasek-Bal; Michał Holecki; Bartłomiej Kret; Anna Hawrot-Kawecka; Jan Duława
Journal:  Med Sci Monit       Date:  2014-08-07

9.  Mild hyponatremia, hypernatremia and incident cardiovascular disease and mortality in older men: A population-based cohort study.

Authors:  S G Wannamethee; A G Shaper; L Lennon; O Papacosta; P Whincup
Journal:  Nutr Metab Cardiovasc Dis       Date:  2015-08-05       Impact factor: 4.222

10.  Effect of Hemoglobin A1c Reduction or Weight Reduction on Blood Pressure in Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Treatment in Type 2 Diabetes Mellitus: A Meta-Analysis.

Authors:  Mengdie Hu; Xiaoling Cai; Wenjia Yang; Simin Zhang; Lin Nie; Linong Ji
Journal:  J Am Heart Assoc       Date:  2020-03-30       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.